Increasing the survival factor sulfiredoxin-1 and senescence marker protein 30 or inhibiting serine/threonine protein kinase 25 can activate the AKT/GSK-3β/Nrf2 pathway and protect RGCs from hyperglycemia-induced oxidative damage [157–159]. Here, NFE2L2 is linked to Hyperglycemia.